[ Price : $8.95]
AbbVie reports positive top-line results from SELECT-GCA, a Phase 3, placebo-controlled study that showed the companys arthritis d...[ Price : $8.95]
GlaxoSmithKline says a follow-up trial of its Shingrix found 80% effectiveness in adults over age 50 up to 11 years after vaccinat...[ Price : $8.95]
Philips Respironics recalls its Trilogy Evo ventilator and all software versions, except 1.05.06.00, due to the devices potential ...[ Price : $8.95]
FDA approves Lumicells Lumisight to assist in the detection of cancerous tissue in breast cancer patients undergoing a lumpectomy....[ Price : $8.95]
Federal Register notice: FDA issues a priority review voucher to Orchard Therapeutics for its rare pediatric disease drug approval...[ Price : $8.95]
Federal Register notice: FDA sends to OMB an information collection extension entitled Expedited Programs for Serious Conditions ...[ Price : $8.95]
CDER Office of Medical Policy regulatory counsel Christopher Diamant explains why the new Patient Medication Information form was ...[ Price : $8.95]
Two Polsinelli attorneys say the Supreme Courts refusal to hear an appeal in a labeling case helps manufacturers argue for preempt...